Do Analysts Recommend VTR at $48.26?

By Ken Smith • Tuesday, July 04 09:40 • Permanent Link

The large-cap Specialty Real Estate Investment Trust company is now trading -11.03% below its average target price of $54.24. Analysts have set target prices ranging from $45.0 to $80.0 per share for Ventas, and have given the stock an average rating of buy.

Ventas's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.2%. The stock's short ratio is 3.5. The company's insiders own 0.54% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 98.5%. In conclusion, we believe there is mixed market sentiment regarding Ventas.

Institutions Invested in Ventas

Date Reported	Holder	Percentage	Shares	Value
2023-03-31	Vanguard Group, Inc. (The)	16%	65,787,670	$3,174,912,843
2023-03-31	Blackrock Inc.	11%	42,865,841	$2,068,705,414
2023-03-31	State Street Corporation	7%	28,850,569	$1,392,328,411
2023-03-31	JP Morgan Chase & Company	6%	24,242,954	$1,169,964,919
2023-03-31	FMR, LLC	5%	18,510,819	$893,332,093
2023-03-31	Apg Asset Management US Inc.	5%	18,160,250	$876,413,634
2023-03-31	Principal Financial Group, Inc.	4%	16,967,816	$818,866,771
2023-03-31	Geode Capital Management, LLC	2%	9,157,232	$441,928,000
2023-03-31	CenterSquare Investment Management LLC	2%	6,125,661	$295,624,389
2023-03-31	Dimensional Fund Advisors LP	1%	5,685,860	$274,399,594

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.